Developer docs
API playgroundTry for free, no card

Search company profiles

NEXT NEW WORLD

Full company profile

uuid002lvh2

Namestring
NEXT NEW WORLD
Legal namestring
株式会社 NEXT NEW WORLD
Company typeenum
Private
Founded yearint
2021
Descriptiontext

NEXT NEW WORLD is a Japanese biotech venture founded in June 2021 and headquartered in Kiryu, Gunma Prefecture, with a secondary office in Minato-ku, Tokyo. The company develops and commercializes a proprietary patented silk protein technology branded Karada Silk® (カラダシルク®), which is described as the world's first method to dissolve silk fibroin into a water solution while preserving its native nano-level porous mesh structure — a structural integrity that conventional liquid silk processing destroys. NEXT NEW WORLD applies this platform across healthcare, food, cosmetics, and materials verticals.

The company operates a dual-track business model. On the direct-to-consumer side, it runs three sub-brands sold through their own websites: ZINZO, a preservative-free human healthcare silk protein drink; SILKFULL, a pet healthcare brand for dogs and cats targeting kidney and intestinal health; and SILKCATS, a cat-specific wellness brand. On the B2B side, the company pursues technology licensing and co-development partnerships with major Japanese corporations — including equity-invested partners Ajinomoto, Pola Orbis Holdings, and Estee Corporation — leveraging their distribution channels to embed Karada Silk® into adjacent product categories, particularly pet nutrition.

NEXT NEW WORLD is a venture-backed private company with 1–10 employees. It completed a 240 million yen (~$1.5M) Series A funding round in June 2026 at a 1.28 billion yen post-money valuation, led by 15th Rock with broad participation from strategic corporate investors and financial investors including Shinkin Capital and Mizuho Capital. The company maintains joint research relationships with Temasek Polytechnic (Singapore), Kindai University, Shinshu University Faculty of Textile Science, and Yokohama City University School of Medicine, and sources its raw silk exclusively from GOTS-certified organic producers. Leadership comprises CEO Kotaro Takashima (former Amazon Japan executive) and Director Kyhei Asahi (former Deloitte Tohmatsu Consulting).

Short descriptiontext

NEXT NEW WORLD is a Japanese biotech startup that developed Karada Silk®, a patented water-soluble silk protein technology preserving nano-level mesh structure, and commercializes it via DTC health brands (ZINZO, SILKFULL, SILKCATS) and B2B licensing deals with major Japanese corporates.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKiryu, Japan
HQ citystring
Kiryu
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
silk protein technology, pet healthcare supplements, human wellness supplements, biotech research development, natural ingredient cosmetics
Industry1 code
PRIMARYIMAOAMAM
Biobased, Compostable & Low-Impact Material Innovation (Bio-polymers/Dope Dyeing)
NAICS code1 code
  • Textile Mills313
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Biotech Consumer Health Products
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Consumer Healthcare Products
TypeOne Time License
Description

Direct-to-consumer sales of silk protein-based health supplements for humans (ZINZO) and pets (SILKFULL, SILKCATS). Products are sold through brand websites.

nextnewworld.co
2B2B Licensing & Co-development
TypeLicensing Royalties
Description

Technology licensing and co-development partnerships with major corporations in healthcare, food, cosmetics, and materials industries. Includes strategic investments from partners like Ajinomoto, Pola Orbis Holdings, and Estee.

nextnewworld.co
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1ZINZO
Description

Human healthcare silk drink using Karada Silk as main ingredient, preservative-free.

nextnewworld.co
+2 more records
Core offering1 text field

NEXT NEW WORLD researches and commercializes proprietary silk protein technology (Karada Silk®) that maintains nano-level mesh structure in water-soluble form. The company sells consumer healthcare products under the ZINZO brand (human silk protein drinks) and the SILKFULL/SILKCATS brands (pet healthcare for cats and dogs), while pursuing B2B co-development and licensing partnerships with major Japanese corporations in food, cosmetics, healthcare, and materials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 8% CAGR growth rate in silk market
+1 more record
Product and service3 records
1ZINZO
CategoryHuman Healthcare Consumer Product
Description

Human healthcare silk protein drink using Karada Silk® as the main ingredient, with no preservatives, targeting the human health and wellness market.

2SILKFULL
CategoryPet Healthcare Consumer Product
Description

Pet healthcare brand for cats and dogs utilizing Karada Silk® to support kidney and intestinal health, positioned in the pet wellness market.

3SILKCATS
CategoryPet Healthcare Consumer Product
Description

Pet wellness brand for cats developed by NEXT NEW WORLD, leveraging silk protein technology to address feline health and nutrition needs.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

International research partner in Singapore conducting joint research on silk applications and versatility.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Research partner in Osaka, Japan conducting joint research on silk applications and versatility.

3Shinshu University Faculty of Textile Science (信州大学 繊維学部)
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Research partner in Nagano, Japan specializing in textile science conducting joint research on silk applications.

nextnewworld.co
4Yokohama City University School of Medicine (横浜市立大学 医学部)
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Research partner in Kanagawa, Japan in medical field conducting joint research on silk health applications.

nextnewworld.co
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AMSilk is a German company producing silk protein-based materials for medical and cosmetic applications. It is directly comparable to NEXT NEW WORLD's Karada Silk®; both develop silk proteins for healthcare and consumer applications using proprietary biotechnological processes.

TypeDirect peer
Description

Bolt Threads is a US biotech producing bioengineered silk proteins via fermentation, directly comparable to NEXT NEW WORLD's Karada Silk® technology. Both companies focus on producing silk proteins through proprietary processes for cosmetics, personal care, and materials applications.

TypeDirect peer
Description

Spiber is a Japanese biotech company producing protein-based materials through fermentation (Brewed Protein™). It is the most direct comparable to NEXT NEW WORLD: both are Japanese biotech firms developing novel protein materials with sustainability positioning for textile, cosmetic, and industrial applications.

4Shiseido
TypeBroad incumbent
Description

Shiseido is a major Japanese cosmetics incumbent. NEXT NEW WORLD's technology has stated cosmetics applications (per Pola Orbis partnership), placing Shiseido in the comparable set as a potential competitor, acquirer, or partner in Japanese beauty/health.

TypeDirect peer
Description

Modern Meadow is a US biotech developing bioengineered protein materials (collagen and others) for fashion and consumer applications. It shares NEXT NEW WORLD's biotech-driven protein-materials approach and target verticals, though focused on different protein types.

TypeBroad incumbent
Description

Elanco is a major animal health company providing pharmaceuticals and nutritional supplements for pets. It is comparable to NEXT NEW WORLD's pet healthcare business as both target the pet wellness category with health-focused offerings across multiple species.

TypeBroad incumbent
Description

Nestlé Purina is a global leader in pet nutrition and wellness. It is comparable to NEXT NEW WORLD's SILKFULL and SILKCATS brands as both serve the pet nutrition/health market with science-backed offerings, though at vastly different scales.

TypeBroad incumbent
Description

Virbac is a global animal health company developing pharmaceutical and nutritional products for pets. It is comparable to NEXT NEW WORLD's SILKFULL and SILKCATS pet healthcare brands as both serve the pet wellness market, though Virbac operates at much larger scale and global reach.

TypeEmerging player
Description

Euglena is a Japanese biotech company developing microalgae-based health and food products. It is comparable to NEXT NEW WORLD as both are Japanese biotech firms commercializing novel bio-based materials with sustainability positioning into consumer health and food verticals.

10Pola Orbis Holdings
TypeBroad incumbent
Description

Pola Orbis Holdings is a major Japanese cosmetics holding company and a strategic investor in NEXT NEW WORLD. Both companies operate in the Japanese health/beauty space and have a direct commercial relationship through the Series A partnership.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NEXT NEW WORLD

Biotech Consumer Health Productscorp.nextnewworld.co

NEXT NEW WORLD is a Japanese biotech startup that developed Karada Silk®, a patented water-soluble silk protein technology preserving nano-level mesh structure, and commercializes it via DTC health brands (ZINZO, SILKFULL, SILKCATS) and B2B licensing deals with major Japanese corporates.

What NEXT NEW WORLD does

NEXT NEW WORLD is a Japanese biotech venture founded in June 2021 and headquartered in Kiryu, Gunma Prefecture, with a secondary office in Minato-ku, Tokyo. The company develops and commercializes a proprietary patented silk protein technology branded Karada Silk® (カラダシルク®), which is described as the world's first method to dissolve silk fibroin into a water solution while preserving its native nano-level porous mesh structure — a structural integrity that conventional liquid silk processing destroys. NEXT NEW WORLD applies this platform across healthcare, food, cosmetics, and materials verticals.

The company operates a dual-track business model. On the direct-to-consumer side, it runs three sub-brands sold through their own websites: ZINZO, a preservative-free human healthcare silk protein drink; SILKFULL, a pet healthcare brand for dogs and cats targeting kidney and intestinal health; and SILKCATS, a cat-specific wellness brand. On the B2B side, the company pursues technology licensing and co-development partnerships with major Japanese corporations — including equity-invested partners Ajinomoto, Pola Orbis Holdings, and Estee Corporation — leveraging their distribution channels to embed Karada Silk® into adjacent product categories, particularly pet nutrition.

NEXT NEW WORLD is a venture-backed private company with 1–10 employees. It completed a 240 million yen (~$1.5M) Series A funding round in June 2026 at a 1.28 billion yen post-money valuation, led by 15th Rock with broad participation from strategic corporate investors and financial investors including Shinkin Capital and Mizuho Capital. The company maintains joint research relationships with Temasek Polytechnic (Singapore), Kindai University, Shinshu University Faculty of Textile Science, and Yokohama City University School of Medicine, and sources its raw silk exclusively from GOTS-certified organic producers. Leadership comprises CEO Kotaro Takashima (former Amazon Japan executive) and Director Kyhei Asahi (former Deloitte Tohmatsu Consulting).

NEXT NEW WORLD firmographics

Firmographics
Name
NEXT NEW WORLD
Legal name
株式会社 NEXT NEW WORLD
Website
https://corp.nextnewworld.co
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
NEXT NEW WORLD is a Japanese biotech startup that developed Karada Silk®, a patented water-soluble silk protein technology preserving nano-level mesh structure, and commercializes it via DTC health brands (ZINZO, SILKFULL, SILKCATS) and B2B licensing deals with major Japanese corporates.
Ownership category
akta.pro rank

NEXT NEW WORLD industry classification

Industry
Product category
Biotech Consumer Health Products
NAICS
Textile Mills (313)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYIMAOAMAM
Biobased, Compostable & Low-Impact Material Innovation (Bio-polymers/Dope Dyeing)

Keywords

  • Silk protein technology
  • Pet healthcare supplements
  • Human wellness supplements
  • Biotech research development
  • Natural ingredient cosmetics

Where NEXT NEW WORLD is headquartered

Location

Headquarters

HQ city
Kiryu
HQ country
Japan
HQ region
Asia

Offices2 records

Markets served

NEXT NEW WORLD business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Consumer Healthcare Products: Direct-to-consumer sales of silk protein-based health supplements for humans (ZINZO) and pets (SILKFULL, SILKCATS). Products are sold through brand websites.
  2. B2B Licensing & Co-development: Technology licensing and co-development partnerships with major corporations in healthcare, food, cosmetics, and materials industries. Includes strategic investments from partners like Ajinomoto, Pola Orbis Holdings, and Estee.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

NEXT NEW WORLD product offering

Product offering

Core offering

NEXT NEW WORLD researches and commercializes proprietary silk protein technology (Karada Silk®) that maintains nano-level mesh structure in water-soluble form. The company sells consumer healthcare products under the ZINZO brand (human silk protein drinks) and the SILKFULL/SILKCATS brands (pet healthcare for cats and dogs), while pursuing B2B co-development and licensing partnerships with major Japanese corporations in food, cosmetics, healthcare, and materials.

Differentiator

Problem solved

Functional benefit

Brands

  • ZINZO: Human healthcare silk drink using Karada Silk as main ingredient, preservative-free.
  • SILKFULL
  • SILKCATS

Products and services

  • ZINZO Human healthcare silk protein drink using Karada Silk® as the main ingredient, with no preservatives, targeting the human health and wellness market.
  • SILKFULL Pet healthcare brand for cats and dogs utilizing Karada Silk® to support kidney and intestinal health, positioned in the pet wellness market.
  • SILKCATS Pet wellness brand for cats developed by NEXT NEW WORLD, leveraging silk protein technology to address feline health and nutrition needs.

Quantifiable outcome

  • 8% CAGR growth rate in silk market
  • +1 more outcomes

Companies that use NEXT NEW WORLD

Customer profile

Segments3 records

Ideal customer profiles3 records

NEXT NEW WORLD technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

NEXT NEW WORLD partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered supporting.

  • Temasek PolytechnicsupportingStrategic or Co-development PartnerInternational research partner in Singapore conducting joint research on silk applications and versatility.
  • Kindai University (近畿大学)supportingStrategic or Co-development PartnerResearch partner in Osaka, Japan conducting joint research on silk applications and versatility.
  • Shinshu University Faculty of Textile Science (信州大学 繊維学部)supportingStrategic or Co-development PartnerResearch partner in Nagano, Japan specializing in textile science conducting joint research on silk applications.
  • Yokohama City University School of Medicine (横浜市立大学 医学部)supportingStrategic or Co-development PartnerResearch partner in Kanagawa, Japan in medical field conducting joint research on silk health applications.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

NEXT NEW WORLD competitors and assessment

Company assessment

Direct peers

  • AMSilk: AMSilk is a German company producing silk protein-based materials for medical and cosmetic applications. It is directly comparable to NEXT NEW WORLD's Karada Silk®; both develop silk proteins for healthcare and consumer applications using proprietary biotechnological processes.
  • Bolt Threads: Bolt Threads is a US biotech producing bioengineered silk proteins via fermentation, directly comparable to NEXT NEW WORLD's Karada Silk® technology. Both companies focus on producing silk proteins through proprietary processes for cosmetics, personal care, and materials applications.
  • Spiber: Spiber is a Japanese biotech company producing protein-based materials through fermentation (Brewed Protein™). It is the most direct comparable to NEXT NEW WORLD: both are Japanese biotech firms developing novel protein materials with sustainability positioning for textile, cosmetic, and industrial applications.
  • Modern Meadow: Modern Meadow is a US biotech developing bioengineered protein materials (collagen and others) for fashion and consumer applications. It shares NEXT NEW WORLD's biotech-driven protein-materials approach and target verticals, though focused on different protein types.

Broad incumbents

  • Shiseido: Shiseido is a major Japanese cosmetics incumbent. NEXT NEW WORLD's technology has stated cosmetics applications (per Pola Orbis partnership), placing Shiseido in the comparable set as a potential competitor, acquirer, or partner in Japanese beauty/health.
  • Elanco Animal Health: Elanco is a major animal health company providing pharmaceuticals and nutritional supplements for pets. It is comparable to NEXT NEW WORLD's pet healthcare business as both target the pet wellness category with health-focused offerings across multiple species.
  • Nestlé Purina: Nestlé Purina is a global leader in pet nutrition and wellness. It is comparable to NEXT NEW WORLD's SILKFULL and SILKCATS brands as both serve the pet nutrition/health market with science-backed offerings, though at vastly different scales.
  • Virbac: Virbac is a global animal health company developing pharmaceutical and nutritional products for pets. It is comparable to NEXT NEW WORLD's SILKFULL and SILKCATS pet healthcare brands as both serve the pet wellness market, though Virbac operates at much larger scale and global reach.
  • Pola Orbis Holdings: Pola Orbis Holdings is a major Japanese cosmetics holding company and a strategic investor in NEXT NEW WORLD. Both companies operate in the Japanese health/beauty space and have a direct commercial relationship through the Series A partnership.

Emerging players

  • Euglena: Euglena is a Japanese biotech company developing microalgae-based health and food products. It is comparable to NEXT NEW WORLD as both are Japanese biotech firms commercializing novel bio-based materials with sustainability positioning into consumer health and food verticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

NEXT NEW WORLD compliance and trust

Trust signal

Compliance1 record

NEXT NEW WORLD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NEXT NEW WORLD leadership team

Management profile

Number of profiles

Profiles2 records

NEXT NEW WORLD funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NEXT NEW WORLD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NEXT NEW WORLD

What does NEXT NEW WORLD do?

NEXT NEW WORLD researches and commercializes proprietary silk protein technology (Karada Silk®) that maintains nano-level mesh structure in water-soluble form. The company sells consumer healthcare products under the ZINZO brand (human silk protein drinks) and the SILKFULL/SILKCATS brands (pet healthcare for cats and dogs), while pursuing B2B co-development and licensing partnerships with major Japanese corporations in food, cosmetics, healthcare, and materials.

Is NEXT NEW WORLD a public or private company?

NEXT NEW WORLD is a private company. It is classified as venture growth investor backed and is currently operating.

When was NEXT NEW WORLD founded?

NEXT NEW WORLD was founded in 2021. It employs 1 to 10 people.

Where is NEXT NEW WORLD based?

NEXT NEW WORLD is headquartered in Kiryu, Japan, in the Asia region.

How does NEXT NEW WORLD make money?

Two revenue lines are on record. Consumer Healthcare Products are the primary driver. The others are B2B Licensing & Co-development.

Who are NEXT NEW WORLD's main competitors?

Direct peers on record are AMSilk, Bolt Threads, Spiber and Modern Meadow. Broad incumbents are Shiseido, Elanco Animal Health, Nestlé Purina, Virbac and Pola Orbis Holdings. Euglena is listed as an emerging player.

Does NEXT NEW WORLD have an API?

No public API is recorded for NEXT NEW WORLD.

What industry is NEXT NEW WORLD in?

NEXT NEW WORLD's product category is Biotech Consumer Health Products. Its primary akta.pro industry code is IMAOAMAM, Biobased, Compostable & Low-Impact Material Innovation (Bio-polymers/Dope Dyeing). Its NAICS code is 313 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ThebridgeSilk Protein-Based Healthcare Business “NEXT NEW WORLD” Receives Investment from Ajinomoto and POLANEXT NEW WORLD, a silk protein developer, completed a funding round of about ¥240 million, bringing total raised to ¥450 million. The funds will expand sales of pet products and veterinary hospital channels, with plans to extend its healthcare initiative to humans.Thebridgeシルクタンパク質基盤のヘルスケア事業「NEXT NEW WORLD」味の素やポーラなど出資NEXT NEW WORLD, a silk protein health company, raised about 450 million yen in funding, including third-party shares, convertible bonds, and debt. The company sells pet and veterinary products and a human drink, with over 2,800 handling locations and 1,200 hospitals adopting its veterinary products. It plans to expand sales and develop human healthcare products.Third NewsEstée Invests in NEXT NEW WORLD to Innovate Pet Care with Silk Protein TechnologyEstée Corporation announced an investment in NEXT NEW WORLD (NNW), a Japanese pet food and dietary supplement company based in Kiryu, Gunma Prefecture, as part of its strategy to strengthen its pet care division under the medium-term management plan 'SMILE 2027'. NNW, founded in 2021, is the sole company capable of producing soluble silk protein while maintaining structural integrity, and has developed pet wellness brands including 'SILKCATS' for cats and 'SILKFUL' for dogs. The partnership aims to leverage NNW's silk protein technology to develop innovative pet nutrition products while advancing sustainable practices in the pet care industry.